Search Results for 'tdf'

tdf published presentations and documents on DocSlides.

by pasty-toler

of the evidence from oral and topical . PrEP. ef...

The Bangkok Tenofovir Study

The Bangkok Tenofovir Study

by marina-yarberry

An HIV pre-exposure prophylaxis trial in Thailand...

by alida-meadow

based . PrEP. technologies in women : . what do...

Phase 2 of new ARVs

Phase 2 of new ARVs

by mitsue-stanley

Fostemsavir. , . prodrug. of . temsavir. . (. a...

ART as prevention: PEP &

ART as prevention: PEP &

by phoebe-click

PrEP. Dr. Laura Waters. HIV/GU Medicine. Brighto...

by tatiana-dople

de . l’étude. Critère. principal . –. pu...

Switching From a Tenofovir

Switching From a Tenofovir

by yael

. Disoproxil. . Fumarate. (TDF)-Based Regimen to...

Prescribing PrEP in Title X Settings

Prescribing PrEP in Title X Settings

by kaison

Erika Aaron, CRNP. Disclosures. Successful Complet...

When and What To Start Melanie A. Thompson, MD

When and What To Start Melanie A. Thompson, MD

by paxton651

Thacker & Thompson, MD. Atlanta, Georgia. Fina...

Switch to DRV/r + 3TC DUAL Study

Switch to DRV/r + 3TC DUAL Study

by jireh

DRV/r 800/100 + 3TC 300 QD. N = 126. N = 123. DRV/...

Kenneth E. Sherman, MD, PhD

Kenneth E. Sherman, MD, PhD

by heavin

Gould Professor of Medicine. Director, Division of...

Update from CROI 2023: Snippets from Seattle

Update from CROI 2023: Snippets from Seattle

by scarlett

Judith S. Currier, MD, MSc. Professor of Medicine....

PROUD: Results and participant experiences

PROUD: Results and participant experiences

by catherine

Presented by . Mitzy. . Gafos. , behalf of the P...

PRESENTED AT IAS 2021 – the 11th IAS Conference on HIV Science

PRESENTED AT IAS 2021 – the 11th IAS Conference on HIV Science

by bency

|18-21 JULY 2021. Weight gain in children and adol...

PrEP scale up and STI management in Brazil

PrEP scale up and STI management in Brazil

by winnie

Valdilea. G. . Veloso. @. Valdilea. Share your th...

Stephanie Cox Gilead Sciences

Stephanie Cox Gilead Sciences

by emery

Foster City, CA. ULTRASENSITIVE HIV-1 DRUG RESISTA...

Novel Antiretroviral Studies and Strategies

Novel Antiretroviral Studies and Strategies

by danya

Bob Harrington, MD. University of Washington . Pre...

Susan P. Buchbinder, MD Director, Bridge HIV

Susan P. Buchbinder, MD Director, Bridge HIV

by harmony

San . Francisco Department . of Public Health. Cli...

DTG/3TC 1st line (GEMINI)

DTG/3TC 1st line (GEMINI)

by oryan

ARV . strategies. DOR > DRV/r 1st line. (DRIVE-...

HEPATITIS B PART 2 DR MEERA G KOOTTUM;

HEPATITIS B PART 2 DR MEERA G KOOTTUM;

by jacey

. TODAY. DIAGNOSIS. TREATMENT. SPECIAL SITUATIONS....

Introduction Characteristics, Treatment Patterns,

Introduction Characteristics, Treatment Patterns,

by cappi

and . Virologic. Outcomes . for Treatment-experie...

Any PRM at baseline Yes No

Any PRM at baseline Yes No

by lucy

39. 129. 100 . (91, 100). 98 . (95, 100). NRTI PRM...

CROI 2015: Treatment and Cure Highlights

CROI 2015: Treatment and Cure Highlights

by unita

Shireesha Dhanireddy. Robert Harrington. March 17,...

Tryptophane Metabolites Predict Neurocognitive Impairment and Side Effects during Efavirenz

Tryptophane Metabolites Predict Neurocognitive Impairment and Side Effects during Efavirenz

by piper

A nested analysis of the Swear randomized multicen...

Challenging Cases in Antiretroviral Therapy and Panel Discussion

Challenging Cases in Antiretroviral Therapy and Panel Discussion

by gagnon

Paul E. Sax, MD. Professor of Medicine. Harvard Me...

Optimizing HIV treatment

Optimizing HIV treatment

by anderson

Professor Francois Venter. Ezintsha, University of...

Dolutegravir-Lamivudine (

Dolutegravir-Lamivudine (

by audrey

Dovato. ). Last Updated: November 28, 2022. Prepar...

Switching the NRTI Backbone to Tenofovir DF-Emtricitabine

Switching the NRTI Backbone to Tenofovir DF-Emtricitabine

by reese

TOTEM. Switching the NRTI Backbone to Tenofovir DF...

Background Long-term use of antiretroviral therapy (

Background Long-term use of antiretroviral therapy (

by jaena

cART. ) in aged HIV-1-infected individuals could e...

IAS – USA Fall New York Course: Case Discussion

IAS – USA Fall New York Course: Case Discussion

by jalin

Luke . Jerram. Disclosures: Educational grant supp...

CAB for PrEP for Advocates

CAB for PrEP for Advocates

by hadly

Basics of Injectable Cabotegravir. for HIV Prevent...

218RidruejoEAntiviraltreatmentforchronichepatitisBinrenaltransplant

218RidruejoEAntiviraltreatmentforchronichepatitisBinrenaltransplant

by rose

jhep.2017.05.008 ,inpress.[243]DurantelD,ZoulimF.N...

Generic tenofovir disoproxil

Generic tenofovir disoproxil

by SunkissedBabe

fumarate and . emtricitabine. tablets obtained fr...

HIV Transmission PrEP /

HIV Transmission PrEP /

by PeacefulPlace

nPEP. Mark Schweizer, DDS MPH. Director Infection ...

HIV PREVENTION SAMU SUMMARY

HIV PREVENTION SAMU SUMMARY

by FluffyFace

2018. Objectives . To describe the current situati...

Clinical Management of PrEP

Clinical Management of PrEP

by SportyChick

U. sers. . W. ho. Test Positive for HIV. Jean-Mi...

Michael S. Saag , MD Professor of Medicine

Michael S. Saag , MD Professor of Medicine

by roxanne

Associate Dean for Global Health. University of Al...

Viral hepatitis Best of ILC 2018

Viral hepatitis Best of ILC 2018

by roberts

About these slides. These slides provide highlight...

PrEP Case Studies Module 6

PrEP Case Studies Module 6

by bethany

Summary recommendations. …. Oral PrEP containing...

Meg Doherty MD MPH PhD 23 July 2018

Meg Doherty MD MPH PhD 23 July 2018

by jordyn

WHO HQ. The role of DTG based regimens in first- a...